Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis

Muscle and Nerve

Volumn 38, Issue 2, 2008, Pages 957-963

  Burns, Ted M ^a   Conaway, Mark R ^a   Cutter, Gary R ^b   Sanders, Donald B ^c   McDermott, Michael ^d   Thornton, Charles ^d   Tawil, Rabi ^d   Barohn, Richard J ^d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Duke University ^*

Author keywords

Evaluative instrument; Myasthenia gravis; Outcome measure; Quality of life

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; GOLD STANDARD; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; MYASTHENIA GRAVIS SPECIFIC ACTIVITIES OF DAILY LIVING; MYASTHENIA GRAVIS SPECIFIC MANUAL MUSCLE TESTING; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUANTITATIVE MYASTHENIA GRAVIS; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SHORT FORM 36; SOCIAL ASPECT;

ACTIVITIES OF DAILY LIVING; HEALTH SURVEYS; HUMANS; MYASTHENIA GRAVIS; MYCOPHENOLIC ACID; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 49449083294     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21053     Document Type: Article

References (15)

1. Addington-Hall J, Kalra L. Measuring quality of life. Who should measure quality of life? BMJ 2001;322:1417-1420.
2. Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann NY Acad Sci 1998;841:769-772.
3. Burns TM, Conaway M, Sanders DB, and the Muscle Study Group. Effect of quality-of-fife on impairment of various regional domains in myasthenia gravis: MSG CellCept trial experience. The 11th International Conference on Myasthenia Gravis and Related Disorders, May 2007, Chicago, IL.
4. Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Recommendations for clinical research standards. Neurology 2000;55:16-23.
5. Mullins LL, Carpentier MY, Paul RH, Sanders DB, and the Muscle Study Group. A disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve (in press).
6. Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R, et al. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 2001;22:363-369.
7. Padua L, Evoli A, Aprile I, Caliandro P, Batocchi AP, Punzi C, et al. Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurol Sci 2002;23:59-68.
8. Paul RH, Nash, JM, Cohen, RA, Gilchrist, JM, Goldstein JM. Quality of life and well-being of patients with myasthenia gravis. Muscle Nerve 2001;24:512-516.
9. Price P. Defining and measuring quality of life. J Wound Care 1996;5:139-140.
10. Rostcdt A, Padua L, Stalberg EV. Validation of the Swedish version of the disease-specific myasthenia gravis questionnaire. Neurol Sci 2006;27:91-96.
11. Sanders DB, Tucker-Lipscomb B, Massey JM. A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score. Ann NY Acad Sci 2003;998:440-444.
12. Simmons Z, Felgoise SH, Bremer BA, Walsh SM, Hufford DJ, Bromberg MB, et al. The ALSSQOL. Balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology 2006;67:1659-1664.
13. Vincent KA, Carr AJ, Walburn J, Scott DL, Rose MR. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 2007;68:1051-1057.
14. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Med Care 1992;30:473-483.
15. Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 1999;52:1487-1489.